Cargando…

Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B

OBJECTIVE: To develop the Chinese (Mainland) version of Chronic Liver Disease Questionnaire (CLDQ) and use it to assess the health-related quality of life (HRQoL) of chronic hepatitis B (CHB) patients in China and identify the determinants of HRQoL. METHODS: The Chinese (Mainland) CLDQ was developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanli, Zhang, Sai, Zhao, Yali, Du, Juan, Jin, Guanghui, Shao, Shuang, Lu, Xiaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025145/
https://www.ncbi.nlm.nih.gov/pubmed/27631983
http://dx.doi.org/10.1371/journal.pone.0162763
_version_ 1782453906711773184
author Liu, Yanli
Zhang, Sai
Zhao, Yali
Du, Juan
Jin, Guanghui
Shao, Shuang
Lu, Xiaoqin
author_facet Liu, Yanli
Zhang, Sai
Zhao, Yali
Du, Juan
Jin, Guanghui
Shao, Shuang
Lu, Xiaoqin
author_sort Liu, Yanli
collection PubMed
description OBJECTIVE: To develop the Chinese (Mainland) version of Chronic Liver Disease Questionnaire (CLDQ) and use it to assess the health-related quality of life (HRQoL) of chronic hepatitis B (CHB) patients in China and identify the determinants of HRQoL. METHODS: The Chinese (Mainland) CLDQ was developed by expert consultation, focus group interviews with patients, and pilot study. The final version of questionnaire was adopted to assess the HRQoL of chronic hepatitis B outpatients enrolled from two largest infectious hospitals in Beijing. Cronbach’ s alpha was used to measure the internal consistency reliability. The construct validity was measured by factor analysis. T-test, one-way analysis of variance (ANOVA), and multi-variable linear regression were used to analyze the data. RESULTS: Cronbach’s alpha of the overall CLDQ is 0.935, ranging from 0.628 to o.881 among six subscales. Six factors were identified via factor analysis, including a new factor sleeping(SL). A total of 519 patients with CHB were included in the investigation with the final version of questionnaire, 405 of them were only with CHB, 53 with compensated cirrhosis, and 61 with decompensated cirrhosis. The CHB group scored the highest in the overall score of CLDQ (p<0.05). The score of worry (WO) domain was significantly lower in the compensated group than the CHB group (p<0.05). Decompensated cirrhosis patients scored lower than the CHB group in all CLDQ domains and the overall score (p<0.05). Stages of illness, gender, regular visits to specialized hospitals, and work status in last year were determinants of HRQoL. CONCLUSION: The psychometric properties of the Chinese(Mainland) CLDQ is acceptable. The HRQoL of CHB patients deteriorated with disease progression. Advanced stages of CHB, female, long time absence from work after illness, and no job or retirement were determinants of poor HRQoL. Regular visits to specialized hospitals was a positive determinant of HRQoL.
format Online
Article
Text
id pubmed-5025145
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50251452016-09-27 Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B Liu, Yanli Zhang, Sai Zhao, Yali Du, Juan Jin, Guanghui Shao, Shuang Lu, Xiaoqin PLoS One Research Article OBJECTIVE: To develop the Chinese (Mainland) version of Chronic Liver Disease Questionnaire (CLDQ) and use it to assess the health-related quality of life (HRQoL) of chronic hepatitis B (CHB) patients in China and identify the determinants of HRQoL. METHODS: The Chinese (Mainland) CLDQ was developed by expert consultation, focus group interviews with patients, and pilot study. The final version of questionnaire was adopted to assess the HRQoL of chronic hepatitis B outpatients enrolled from two largest infectious hospitals in Beijing. Cronbach’ s alpha was used to measure the internal consistency reliability. The construct validity was measured by factor analysis. T-test, one-way analysis of variance (ANOVA), and multi-variable linear regression were used to analyze the data. RESULTS: Cronbach’s alpha of the overall CLDQ is 0.935, ranging from 0.628 to o.881 among six subscales. Six factors were identified via factor analysis, including a new factor sleeping(SL). A total of 519 patients with CHB were included in the investigation with the final version of questionnaire, 405 of them were only with CHB, 53 with compensated cirrhosis, and 61 with decompensated cirrhosis. The CHB group scored the highest in the overall score of CLDQ (p<0.05). The score of worry (WO) domain was significantly lower in the compensated group than the CHB group (p<0.05). Decompensated cirrhosis patients scored lower than the CHB group in all CLDQ domains and the overall score (p<0.05). Stages of illness, gender, regular visits to specialized hospitals, and work status in last year were determinants of HRQoL. CONCLUSION: The psychometric properties of the Chinese(Mainland) CLDQ is acceptable. The HRQoL of CHB patients deteriorated with disease progression. Advanced stages of CHB, female, long time absence from work after illness, and no job or retirement were determinants of poor HRQoL. Regular visits to specialized hospitals was a positive determinant of HRQoL. Public Library of Science 2016-09-15 /pmc/articles/PMC5025145/ /pubmed/27631983 http://dx.doi.org/10.1371/journal.pone.0162763 Text en © 2016 Liu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Liu, Yanli
Zhang, Sai
Zhao, Yali
Du, Juan
Jin, Guanghui
Shao, Shuang
Lu, Xiaoqin
Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B
title Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B
title_full Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B
title_fullStr Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B
title_full_unstemmed Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B
title_short Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B
title_sort development and application of the chinese (mainland) version of chronic liver disease questionnaire to assess the health-related quality of life (hrqol) in patients with chronic hepatitis b
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025145/
https://www.ncbi.nlm.nih.gov/pubmed/27631983
http://dx.doi.org/10.1371/journal.pone.0162763
work_keys_str_mv AT liuyanli developmentandapplicationofthechinesemainlandversionofchronicliverdiseasequestionnairetoassessthehealthrelatedqualityoflifehrqolinpatientswithchronichepatitisb
AT zhangsai developmentandapplicationofthechinesemainlandversionofchronicliverdiseasequestionnairetoassessthehealthrelatedqualityoflifehrqolinpatientswithchronichepatitisb
AT zhaoyali developmentandapplicationofthechinesemainlandversionofchronicliverdiseasequestionnairetoassessthehealthrelatedqualityoflifehrqolinpatientswithchronichepatitisb
AT dujuan developmentandapplicationofthechinesemainlandversionofchronicliverdiseasequestionnairetoassessthehealthrelatedqualityoflifehrqolinpatientswithchronichepatitisb
AT jinguanghui developmentandapplicationofthechinesemainlandversionofchronicliverdiseasequestionnairetoassessthehealthrelatedqualityoflifehrqolinpatientswithchronichepatitisb
AT shaoshuang developmentandapplicationofthechinesemainlandversionofchronicliverdiseasequestionnairetoassessthehealthrelatedqualityoflifehrqolinpatientswithchronichepatitisb
AT luxiaoqin developmentandapplicationofthechinesemainlandversionofchronicliverdiseasequestionnairetoassessthehealthrelatedqualityoflifehrqolinpatientswithchronichepatitisb